Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | “Adding New Dimensions to Drug Discovery:As Pharmacovigilance is becoming an important part of drug development as it deals with the patient’s safety keeping this in mind IBRI conducts Certificate Course in Pharmcovigilance.
By: IBRI NOIDA UP Certificate course is a skill development program designed to cover all aspects ofPharmacovigilance and drug safety management. It sensitizes the students and equips them with knowledge on Pharmacovigilancepractices worldwide and on the Indian scenario in detail. This course gives young executives an opportunity to remain ahead of competitors in a very nascent yet competitive environment. Eligibility To participate in the program of Pharmacovigilance, the eligibility criteria is as follows: Graduates in Pharmacy and Bio-Sciences, Medical Professionals, i.e Doctors of all disciplines, graduates in pharmacy and bio-sciences and junior professionals in Pharmaceutical and IT Industry, Clinical Research Organization are eligible for the course. Course-Structure Course-Paper- Course-Paper- Course-Paper- Course-Paper- Course-Duration: Course Fees: Rs.7000/ How to Apply: To enroll for the course you have to follow following four steps: 1 Download the Registration Form 2 Fill the form and attach the required documents. 3 Fees Submission: Examination and Evaluation Process: - One time examination and mode of examination are · Assignment Based Examination · Examination Center based Examination · Evaluation by experts from industry and academic team of institute. Course fees can be submitted by DD or Cheque in favour of “IBRI- Unit of Exordior Technical Services Pvt Ltd” and payable at “NOIDA”. Or by NEFT to institute account. Beneficiary Name- IBRI- Unit of Exordior Technical Services Private limited. Address- Beneficiary Account No: - 914020014746404 Bank IFSC Code: - UTIB0000022 Bank Name: - AXIS BANK Branch Address: - SECTOR 16, NOIDA 201301 (UP) The admissions are open and you are welcome for the program. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|